• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种免疫复合物的晶体结构鉴定了人乳头瘤病毒感染性和型特异性中和的决定因素。

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus.

机构信息

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, China.

National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public Health, Xiamen University, Xiamen, China.

出版信息

mBio. 2017 Sep 26;8(5):e00787-17. doi: 10.1128/mBio.00787-17.

DOI:10.1128/mBio.00787-17
PMID:28951471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5615192/
Abstract

Persistent, high-risk human papillomavirus (HPV) infection is the primary cause of cervical cancer. Neutralizing antibodies elicited by L1-only virus-like particles (VLPs) can block HPV infection; however, the lack of high-resolution structures has limited our understanding of the mode of virus infection and the requirement for type specificity at the molecular level. Here, we describe two antibodies, A12A3 and 28F10, that specifically bind to and neutralize HPV58 and HPV59, respectively, through two distinct binding stoichiometries. We show that the epitopes of A12A3 are clustered in the DE loops of two adjacent HPV58 L1 monomers, whereas 28F10 recognizes the HPV59 FG loop of a single monomer. Via structure-based mutagenesis and analysis of antibody binding, we further identified the residues HPV58 D154, S168, and N170 and HPV59 M267, Q270, E273, Y276, K278, and R283, which play critical roles in virus infection. By substituting these strategic epitope residues into other HPV genotypes, we could then redirect the type-specific binding of the antibodies to these genotypes, thus highlighting the importance of these specific residues, HPV58 R161, S168, and N308 and HPV59 Q270, E273, and D281. Overall, our findings provide molecular insights into potential structural determinants of HPV required for infectivity and type specificity. High-risk human papillomaviruses (HPVs) are considered the major causative pathogens of cancers that affect epithelial mucosa, such as cervical cancer. However, because of the lack of high-resolution structural information on the sites of neutralization, we have yet to determine the precise mode of HPV infection and how different types of HPV cause infection. Our crystal structures in this study have uncovered discrete binding stoichiometries for two different antibodies. We show that one A12A3 Fab binds to the center of one HPV58 pentamer, whereas five 28F10 Fabs bind along the top fringe of one HPV59 pentamer. Furthermore, through targeted epitope analysis, we show that 6 to 7 discontinuous residues of the L1 major capsid protein of HPV are determinants, at least in part, for virus infection and type specificity. This knowledge will help us to unravel the process of HPV infection and can potentially be used to drive the development of therapeutics that target neutralization-sensitive sites.

摘要

持续存在的高危型人乳头瘤病毒(HPV)感染是宫颈癌的主要病因。仅由 L1 组成的病毒样颗粒(VLPs)产生的中和抗体可阻断 HPV 感染;然而,缺乏高分辨率结构限制了我们对病毒感染模式和分子水平上所需的型特异性的理解。在这里,我们描述了两种抗体,A12A3 和 28F10,它们分别通过两种不同的结合化学计量特异性结合并中和 HPV58 和 HPV59。我们表明,A12A3 的表位聚集在两个相邻 HPV58 L1 单体的 DE 环中,而 28F10 识别单个单体的 HPV59 FG 环。通过基于结构的诱变和抗体结合分析,我们进一步确定了 HPV58 D154、S168 和 N170 和 HPV59 M267、Q270、E273、Y276、K278 和 R283 残基在病毒感染中起关键作用。通过将这些关键表位残基替换为其他 HPV 基因型,我们可以将抗体的特定型结合重新定向到这些基因型上,从而突出这些特定残基 HPV58 R161、S168 和 N308 和 HPV59 Q270、E273 和 D281 的重要性。总的来说,我们的研究结果提供了 HPV 感染和型特异性所需的潜在结构决定因素的分子见解。高危型人乳头瘤病毒(HPV)被认为是影响上皮粘膜的癌症的主要病原体,如宫颈癌。然而,由于缺乏中和位点的高分辨率结构信息,我们尚未确定 HPV 感染的确切模式以及不同类型的 HPV 如何引起感染。我们在这项研究中的晶体结构揭示了两种不同抗体的离散结合化学计量。我们表明,一个 A12A3 Fab 结合在一个 HPV58 五聚体的中心,而五个 28F10 Fab 结合在一个 HPV59 五聚体的顶部边缘。此外,通过靶向表位分析,我们表明 HPV L1 主要衣壳蛋白的 6 到 7 个不连续残基至少部分决定了病毒感染和型特异性。这一知识将帮助我们解开 HPV 感染的过程,并可能被用来推动针对中和敏感位点的治疗药物的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/86a139c4b273/mbo0041734790007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/63d4f0f38ac5/mbo0041734790001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/32901e84ee1c/mbo0041734790002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/ab506df274e0/mbo0041734790003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/58ba7e12c784/mbo0041734790004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/2cf75b755b24/mbo0041734790005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/fa162ee47a9a/mbo0041734790006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/86a139c4b273/mbo0041734790007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/63d4f0f38ac5/mbo0041734790001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/32901e84ee1c/mbo0041734790002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/ab506df274e0/mbo0041734790003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/58ba7e12c784/mbo0041734790004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/2cf75b755b24/mbo0041734790005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/fa162ee47a9a/mbo0041734790006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/587c/5615192/86a139c4b273/mbo0041734790007.jpg

相似文献

1
Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus.两种免疫复合物的晶体结构鉴定了人乳头瘤病毒感染性和型特异性中和的决定因素。
mBio. 2017 Sep 26;8(5):e00787-17. doi: 10.1128/mBio.00787-17.
2
Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.全面评估人乳头瘤病毒谱系变异对基于疫苗相关基因型主要衣壳蛋白的中和单克隆抗体识别的抗原性影响
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01236-20.
3
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.由L1/L2嵌合病毒样颗粒组成的人乳头瘤病毒疫苗在临床前模型中诱导产生广泛的交叉保护作用。
J Virol. 2016 Jun 24;90(14):6314-25. doi: 10.1128/JVI.00449-16. Print 2016 Jul 15.
4
Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.人乳头瘤病毒33型主要衣壳蛋白中中和表位的特性分析
Virol J. 2006 Oct 2;3:83. doi: 10.1186/1743-422X-3-83.
5
Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection.人乳头瘤病毒-6 的中和位点与病毒感染的病毒附着和进入阶段有关。
Emerg Microbes Infect. 2019;8(1):1721-1733. doi: 10.1080/22221751.2019.1694396.
6
Functional assessment and structural basis of antibody binding to human papillomavirus capsid.抗体与人乳头瘤病毒衣壳结合的功能评估及结构基础
Rev Med Virol. 2016 Mar;26(2):115-28. doi: 10.1002/rmv.1867. Epub 2015 Dec 17.
7
Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies.人乳头瘤病毒 58 衣壳蛋白自然变异对型特异性中和抗体识别的影响。
J Infect Dis. 2018 Oct 5;218(10):1611-1621. doi: 10.1093/infdis/jiy354.
8
Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies.四种人乳头瘤病毒L1衣壳蛋白的晶体结构:了解中和单克隆抗体的特异性
J Biol Chem. 2007 Oct 26;282(43):31803-11. doi: 10.1074/jbc.M706380200. Epub 2007 Sep 4.
9
Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.人乳头瘤病毒16型主要衣壳蛋白FG表面环上的突变会影响型特异性中和抗体和交叉反应抗体的识别。
J Med Virol. 2005 Dec;77(4):558-65. doi: 10.1002/jmv.20492.
10
Immunological analyses of human papillomavirus capsids.人乳头瘤病毒衣壳的免疫学分析
Vaccine. 2001 Feb 8;19(13-14):1783-93. doi: 10.1016/s0264-410x(00)00370-4.

引用本文的文献

1
The h4 coil surface region of human papillomavirus type 58 L1 virus-like particle serves as a potential location for presenting the RG1 epitope peptide.人乳头瘤病毒58型L1病毒样颗粒的h4线圈表面区域可作为呈递RG1表位肽的潜在位置。
Hum Vaccin Immunother. 2025 Dec;21(1):2477966. doi: 10.1080/21645515.2025.2477966. Epub 2025 Apr 1.
2
Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses.鉴定一种针对 H1N1 和 H5N1 流感病毒受体结合位点的具有交叉中和作用的抗体。
Nat Commun. 2022 Sep 2;13(1):5182. doi: 10.1038/s41467-022-32926-5.
3
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.

本文引用的文献

1
Cryoelectron Microscopy Maps of Human Papillomavirus 16 Reveal L2 Densities and Heparin Binding Site.Cryoelectron Microscopy Maps of Human Papillomavirus 16 Reveal L2 Densities and Heparin Binding Site. 人乳头瘤病毒 16 的冷冻电子显微镜图谱揭示了 L2 密度和肝素结合位点。
Structure. 2017 Feb 7;25(2):253-263. doi: 10.1016/j.str.2016.12.001. Epub 2017 Jan 5.
2
The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction.人乳头瘤病毒主要衣壳蛋白的C末端臂具有免疫原性并参与病毒与宿主的相互作用。
Structure. 2016 Jun 7;24(6):874-85. doi: 10.1016/j.str.2016.04.008.
3
病毒样颗粒:制备、免疫原性及其作为纳米疫苗和药物纳米载体的作用。
J Nanobiotechnology. 2021 Feb 25;19(1):59. doi: 10.1186/s12951-021-00806-7.
4
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation.人乳头瘤病毒及相关疾病的流行病学和负担、分子发病机制和疫苗评估。
Front Public Health. 2021 Jan 20;8:552028. doi: 10.3389/fpubh.2020.552028. eCollection 2020.
5
Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of binding.三类结合模式不同的人乳头瘤病毒58型抗体共享中和机制的结构基础
J Virol. 2021 Mar 10;95(7). doi: 10.1128/JVI.01587-20. Epub 2021 Jan 20.
6
Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs.一种中和性单克隆抗体H16.001的结构表征,它是用于各种HPV16病毒样颗粒通用效价测定的有力候选物。
NPJ Vaccines. 2020 Sep 23;5:89. doi: 10.1038/s41541-020-00236-w. eCollection 2020.
7
Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.全面评估人乳头瘤病毒谱系变异对基于疫苗相关基因型主要衣壳蛋白的中和单克隆抗体识别的抗原性影响
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01236-20.
8
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.昆虫细胞表达的 SARS-CoV-2 刺突蛋白可在非人灵长类动物中引起高中和抗体滴度。
Emerg Microbes Infect. 2020 Dec;9(1):2076-2090. doi: 10.1080/22221751.2020.1821583.
9
Expression of different L1 isoforms of papillomavirus as mechanism to circumvent adaptive immunity.不同 HPV 长型异构体的表达作为规避适应性免疫的机制。
Elife. 2020 Aug 4;9:e57626. doi: 10.7554/eLife.57626.
10
Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles.通过病毒样颗粒的衣壳-杂交共组装对多价人乳头瘤病毒疫苗进行合理设计。
Nat Commun. 2020 Jun 5;11(1):2841. doi: 10.1038/s41467-020-16639-1.
ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules.
ConSurf 2016:一种用于估计和可视化大分子进化保守性的改进方法。
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50. doi: 10.1093/nar/gkw408. Epub 2016 May 10.
4
The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.通过冷冻电子显微镜鉴定的人乳头瘤病毒16型上的U4抗体表位
J Virol. 2015 Dec;89(23):12108-17. doi: 10.1128/JVI.02020-15. Epub 2015 Sep 23.
5
Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization.四种不同抗体与人乳头瘤病毒 16 相互作用的结构比较及中和机制。
Virology. 2015 Sep;483:253-63. doi: 10.1016/j.virol.2015.04.016. Epub 2015 May 19.
6
Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody.利用交叉中和抗体鉴定用于泛人乳头瘤病毒疫苗开发的广泛基因型人乳头瘤病毒L2中和位点
PLoS One. 2015 Apr 23;10(4):e0123944. doi: 10.1371/journal.pone.0123944. eCollection 2015.
7
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.九价人乳头瘤病毒疫苗预防女性感染和上皮内瘤变。
N Engl J Med. 2015 Feb 19;372(8):711-23. doi: 10.1056/NEJMoa1405044.
8
A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.一项冷冻电子显微镜研究确定了完整的H16.V5表位,并揭示了由中和抗体片段结合引发的整体构象变化。
J Virol. 2015 Jan 15;89(2):1428-38. doi: 10.1128/JVI.02898-14. Epub 2014 Nov 12.
9
Maturation of the human papillomavirus 16 capsid.人乳头瘤病毒16型衣壳的成熟
mBio. 2014 Aug 5;5(4):e01104-14. doi: 10.1128/mBio.01104-14.
10
Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.四价人乳头瘤病毒(6、11、16、18 型)重组疫苗(佳达修(®)):用于预防癌前肛门生殖器病变、宫颈和肛门癌以及生殖器疣的用途介绍。
Drugs. 2014 Jul;74(11):1253-83. doi: 10.1007/s40265-014-0255-z.